Report Overview
Report Summary
Eternity Insights has published a new study on Global Hadron Therapy Market focusing on key segments By Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, Beta Particle Beam), By Application (Pediatric Cancer, Bone And Soft Tissue Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Eye Cancer, Head & Neck Cancer, Others), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Hadron Therapy Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Hadron Therapy Market report is based on robust research methodology designed using blend of research approaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Hadron Therapy Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Hadron Therapy Market Segmentation:
Hadron Therapy Market, By Type
- Electron Beam
- Proton Beam
- Neutron Beam
- Carbon Ion Beam
- Alpha Particle Beam
- Beta Particle Beam
Hadron Therapy Market, By Application
- Pediatric Cancer
- Bone and Soft Tissue Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Eye Cancer
- Head & Neck Cancer
- Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Hadron Therapy market in terms of demand generation. The Hadron Therapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Hadron Therapy market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Hadron Therapy Market Taxonomy:
To learn more about this report
Global Hadron Therapy Market Competitive Landscape
The global Hadron Therapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Koninklijke Philips N.V.
- Advanced Oncotherapy
- Varian Medical Systems
- Optivus Proton Therapy
- Hitachi, Ltd.
- Mevion Medical Systems
- ProTom International
- Mitsubishi Electric Corporation
- Sumitomo Corporation
- ProNova Solutions, LLC
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, Beta Particle Beam |
| By Application Outlook |
Pediatric Cancer, Bone and Soft Tissue Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Eye Cancer, Head & Neck Cancer, Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Koninklijke Philips N.V., Advanced Oncotherapy, Varian Medical Systems, Optivus Proton Therapy, Hitachi, Ltd., Mevion Medical Systems, ProTom International, Mitsubishi Electric Corporation, Sumitomo Corporation, ProNova Solutions, LLC |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table Of Contents
Table of Contents
1 Hadron Therapy Market Overview
1.1 Hadron Therapy Product Overview
1.2 Hadron Therapy Market Segment by Type
1.2.1 Electron Beam
1.2.2 Proton Beam
1.2.3 Neutron Beam
1.2.4 Carbon Ion Beam
1.2.5 Alpha Particle Beam
1.2.6 Beta Particle Beam
1.3 Global Hadron Therapy Market Size by Type
1.3.1 Global Hadron Therapy Sales and Growth by Type
1.3.2 Global Hadron Therapy Sales and Market Share by Type (2017-2020)
1.3.3 Global Hadron Therapy Revenue and Market Share by Type (2017-2020)
1.3.4 Global Hadron Therapy Price by Type (2017-2020)
2 Global Hadron Therapy Market Competition by Company
2.1 Global Hadron Therapy Sales and Market Share by Company (2017-2020)
2.2 Global Hadron Therapy Revenue and Share by Company (2017-2020)
2.3 Global Hadron Therapy Price by Company (2017-2020)
2.4 Global Top Players Hadron Therapy Manufacturing Base Distribution, Sales Area, Product Types
2.5 Hadron Therapy Market Competitive Situation and Trends
2.5.1 Hadron Therapy Market Concentration Rate
2.5.2 Global Hadron Therapy Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Hadron Therapy Company Profiles and Sales Data
3.1 Koninklijke Philips N.V.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Hadron Therapy Product Category, Application and Specification
3.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Advanced Oncotherapy
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Hadron Therapy Product Category, Application and Specification
3.2.3 Advanced Oncotherapy Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Varian Medical Systems
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Hadron Therapy Product Category, Application and Specification
3.3.3 Varian Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Optivus Proton Therapy
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Hadron Therapy Product Category, Application and Specification
3.4.3 Optivus Proton Therapy Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Hitachi, Ltd.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Hadron Therapy Product Category, Application and Specification
3.5.3 Hitachi, Ltd. Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Mevion Medical Systems
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Hadron Therapy Product Category, Application and Specification
3.6.3 Mevion Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 ProTom International
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Hadron Therapy Product Category, Application and Specification
3.7.3 ProTom International Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Mitsubishi Electric Corporation
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Hadron Therapy Product Category, Application and Specification
3.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Sumitomo Corporation
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Hadron Therapy Product Category, Application and Specification
3.9.3 Sumitomo Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 ProNova Solutions, LLC
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Hadron Therapy Product Category, Application and Specification
3.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Hadron Therapy Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Hadron Therapy Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Hadron Therapy Sales and Revenue by Regions
4.2.1 Global Hadron Therapy Sales and Market Share by Regions (2017-2020)
4.2.2 Global Hadron Therapy Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Hadron Therapy Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Hadron Therapy Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Hadron Therapy Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Hadron Therapy Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Hadron Therapy Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Hadron Therapy Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Hadron Therapy Application/End Users
5.1 Hadron Therapy Segment by Application
5.1.1 Pediatric Cancer
5.1.2 Bone and Soft Tissue Cancer
5.1.3 Prostate Cancer
5.1.4 Lung Cancer
5.1.5 Liver Cancer
5.1.6 Eye Cancer
5.1.7 Head & Neck Cancer
5.1.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
5.2 Global Hadron Therapy Product Segment by Application
5.2.1 Global Hadron Therapy Sales by Application
5.2.2 Global Hadron Therapy Sales and Market Share by Application (2017-2020)
6 Global Hadron Therapy Market Forecast
6.1 Global Hadron Therapy Sales, Revenue Forecast (2021-2027)
6.1.1 Global Hadron Therapy Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Hadron Therapy Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Hadron Therapy Forecast by Regions
6.2.1 North America Hadron Therapy Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Hadron Therapy Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Hadron Therapy Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Hadron Therapy Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Hadron Therapy Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Hadron Therapy Forecast by Type
6.3.1 Global Hadron Therapy Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Electron Beam Gowth Forecast
6.3.3 Proton Beam Gowth Forecast
6.4 Hadron Therapy Forecast by Application
6.4.1 Global Hadron Therapy Sales Forecast by Application (2021-2027)
6.4.2 Global Hadron Therapy Forecast in Pediatric Cancer
6.4.3 Global Hadron Therapy Forecast in Bone and Soft Tissue Cancer
7 Hadron Therapy Upstream Raw Materials
7.1 Hadron Therapy Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Hadron Therapy Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer